PlatformClinical TrialsFor SponsorsFor SitesFor CROsAboutContact
SIGN INRequest a demo →
— ABOUT · WHY WE EXIST

Trial matching is a coordination problem.

Sponsors write protocols. Sites estimate eligible patients from memory. Coordinators comb charts by hand. Patients hear about trials from ads, not their own doctor. Nobody owns the routing. We built Safar to sit there.

REQUEST A WALKTHROUGH →BROWSE TRIALS →
Compass rose over topographic contour lines
— FIG. 01 · WHAT WE'RE LOOKING ATTHREE VIEWS · ONE ROUTE
THE ROUTE
— THE ROUTE

Every match traces a path: protocol to feasibility to chart to clinician. We make each step a logged event.

THE LEDGER
— THE LEDGER

Timestamped matches. Recorded consents. Auditable amendments. The artifact your monitor actually wants.

THE METHOD
— THE METHOD

Routed, reviewed, consented. The right patient reaches the right study through their own care team.

— MANIFESTO · IN ONE BREATH

The eligible patient already exists. They are sitting in a clinic, in a chart, with a doctor who knows them. Trial matching isn't a discovery problem. It's a routing problem. Until we treat it that way, the right patients keep missing the right studies.

— SAFAR CLINICAL · FOUNDING NOTEHOW IT WORKS →
— FIG. 02 · OPERATING PRINCIPLESSIX · NON-NEGOTIABLE

How we work — in six lines.

The model on the left is the routing graph: a sponsor protocol parses, lands in the chart, the care team signs off, the patient signs in. Six rules govern every transit.

Routing model: protocol to site to chart to patient consent
01

Routed, not broadcast

A trial doesn't need another email blast. It needs to land on the one chart where it applies.

02

Clinician in the loop

The care team sees every match before the patient does. No cold outreach.

03

Inside the EHR

Epic, Cerner, Meditech. We work where care already happens.

04

Audited by default

Every match is timestamped. Every consent is recorded. The ledger is the product.

05

Patient-controlled consent

The patient authorizes disclosure, not the vendor. We never move PHI without a signature.

06

Quiet

No noise, no dopamine, no leaderboards. The best workflow is one you don't notice.

— TEAM · CLINICAL · ENGINEERING · REGULATORYOPEN ROLES ↗

A team of clinicians, engineers, and regulators.

01
Clinical
Oncology · real-world data

Physicians who have sat through the screen-fail meetings we're built to prevent.

02
Engineering
EHR integrations

FHIR and HL7 specialists who make charts talk to each other.

03
Regulatory
Part 11 · GCP

The people who write the audit responses sponsors actually read.

04
Platform
Distributed systems

Built for patient records at scale, with consistency that holds up.

05
Clinical ops
Coordinator-led

Coordinators-turned-PMs who know exactly where the friction lives.

06
Partnerships
Sponsors · sites · CROs

The bridge between protocol writers and the clinics that run them.

Topographic survey of Safar's route
— FIG. 03 · THE ROUTE SO FAR2023 · 2026 · LIVE

The journey so far.

2023FoundedSafar started with one question: why do eligible patients keep missing the studies meant for them?
2024EHR-nativeMatching moved inside the chart — where the care team already works.
2025Clinician in the loopEvery match reviewed by the care team before any patient is contacted.
2026TodayWorking with sponsors, sites, and research teams to route the right patient to the right study.
— CONTACT · THREE INBOXESRESPONSE WITHIN 1 BUSINESS DAY
PRESS
press@safarclinical.com

Editorial requests, briefings, and background.

CAREERS
careers@safarclinical.com

Open roles across clinical, engineering, and regulatory.

EVERYTHING ELSE
hello@safarclinical.com

Sponsors, sites, partnerships, and the curious.

— A CALL, NOT A DEMO

Thirty minutes.
One protocol. A real match list.

Share a recent protocol under NDA. We'll return a cohort sketch drawn from de-identified records before the follow-up.

Request a walkthrough →— OR EMAIL HELLO@SAFARCLINICAL.COM